Recent Advances in the Classification of Gynecological Tract Tumors: Updates From the 5th Edition of the World Health Organization "Blue Book"
- PMID: 36596270
- DOI: 10.5858/arpa.2022-0166-RA
Recent Advances in the Classification of Gynecological Tract Tumors: Updates From the 5th Edition of the World Health Organization "Blue Book"
Abstract
Context.—: The World Health Organization Classification of Tumours: Female Genital Tract Tumors, 5th edition, published in September 2020, comes 6 years after the 4th edition, and reflects the monumental leaps made in knowledge about the biology of gynecological tumors. Major changes include revised criteria for the assignment of the site of origin of ovarian and fallopian tube tumors, a revision in the classification of squamous and glandular lesions of the lower genital tract based on human papillomavirus association, and an entire chapter devoted to genetic tumor syndromes. This article highlights the changes in the 5th edition relative to the 4th edition, with a focus on areas of value to routine clinical practice.
Objective.—: To provide a comprehensive update on the World Health Organization classification of gynecological tumors, highlighting in particular updated diagnostic criteria and terminology.
Data sources.—: The 4th and 5th editions of the World Health Organization Classification of Tumours.
Conclusions.—: The World Health Organization has made several changes in the 5th edition of the update on female genital tumors. Awareness of the changes is needed for pathologists' translation into contemporary practice.
© 2023 College of American Pathologists.
Similar articles
-
Recent Advances in Genitourinary Tumors: Updates From the 5th Edition of the World Health Organization Blue Book Series.Arch Pathol Lab Med. 2024 Aug 1;148(8):952-964. doi: 10.5858/arpa.2022-0509-RA. Arch Pathol Lab Med. 2024. PMID: 38031818 Review.
-
Recent Advances in Digestive Tract Tumors: Updates From the 5th Edition of the World Health Organization "Blue Book".Arch Pathol Lab Med. 2021 May 1;145(5):607-626. doi: 10.5858/arpa.2020-0047-RA. Arch Pathol Lab Med. 2021. PMID: 32886739 Review.
-
Recent Advances in the Classification of Bladder Cancer - Updates from the 5th Edition of the World Health Organization Classification of the Urinary and Male Genital Tumors.Bladder Cancer. 2023 Mar 31;9(1):1-14. doi: 10.3233/BLC-220106. eCollection 2023. Bladder Cancer. 2023. PMID: 38994481 Free PMC article. Review.
-
Surgical neuropathology update: a review of changes introduced by the WHO classification of tumours of the central nervous system, 4th edition.Arch Pathol Lab Med. 2008 Jun;132(6):993-1007. doi: 10.5858/2008-132-993-SNUARO. Arch Pathol Lab Med. 2008. PMID: 18517285 Review.
-
The 5th Edition of the World Health Organization Classification of Hematolymphoid Tumors.In: Li W, editor. Leukemia [Internet]. Brisbane (AU): Exon Publications; 2022 Oct 16. Chapter 1. In: Li W, editor. Leukemia [Internet]. Brisbane (AU): Exon Publications; 2022 Oct 16. Chapter 1. PMID: 36395314 Free Books & Documents. Review.
Cited by
-
Clinicopathological Profile of Carcinoma Endometrium in a Single Institution of Kerala, India.J Midlife Health. 2025 Jan-Mar;16(1):96-102. doi: 10.4103/jmh.jmh_191_24. Epub 2025 Apr 5. J Midlife Health. 2025. PMID: 40330233 Free PMC article.
-
Neuroendocrine Tumors of the Endometrium: a Case Series with Clinico-Pathological Analysis and Review of Literature.Indian J Surg Oncol. 2025 Feb;16(1):211-220. doi: 10.1007/s13193-024-02047-0. Epub 2024 Aug 17. Indian J Surg Oncol. 2025. PMID: 40114864
-
Significance of androgen receptor and its potential for anti-androgen/androgen receptor-antagonist therapy in ovarian cancers.PLoS One. 2025 May 20;20(5):e0322744. doi: 10.1371/journal.pone.0322744. eCollection 2025. PLoS One. 2025. PMID: 40392873 Free PMC article.
-
Survival Trends for Uterine Sarcomas from a Tertiary Center: The Oxford Experience.Diseases. 2024 Sep 2;12(9):200. doi: 10.3390/diseases12090200. Diseases. 2024. PMID: 39329869 Free PMC article.
-
Metastatic malignant peripheral nerve sheath tumor of the uterus and cervix: Diagnostic Challenges, prognostic determinants and treatment.Gynecol Oncol Rep. 2024 May 27;54:101422. doi: 10.1016/j.gore.2024.101422. eCollection 2024 Aug. Gynecol Oncol Rep. 2024. PMID: 38881559 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources